Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute and Medium Effects of Freeze-dried Kale to go, New Superfood Supplement to Reduce Metabolic Risk in Saudi Subjects

NCT04904601 is registered in ClinicalTrials.gov with Chair for Biomarkers of Chronic Diseases as lead sponsor.

NCT NCT04904601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04904601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute and Medium Effects of Freeze-dried Kale to go, New Superfood Supplement to Reduce Metabolic Risk in Saudi Subjects
Lead sponsor
Chair for Biomarkers of Chronic Diseases
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2021
Completion date
September 28, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic disease, obesity